Nanoparticles and brain tumor treatment /
Despite progresses in surgery, radiotherapy, and in chemotherapy, an effective curative treatment of gliomas does not yet exist. Mortality is still close to 100% and the average survival of patients with GBM is less than 1 year. The efficacy of current anti-cancer strategies in brain tumors is limit...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York, N.Y. : [New York, N.Y.] (222 East 46th Street, New York, NY 10017) :
ASME ; Momentum Press,
2012.
|
Colección: | Biomedical & nanomedical technologies.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- 1. Introduction.
- 2. Glioma biology
- 2.1 Invasion and angiogenesis.
- 3. Blood-brain barrier
- 3.1 Blood-brain barrier physiology
- 3.2 Blood-brain barrier transport systems.
- 4. Nanomedicine and nanotechnology
- 4.1 Nanoparticle drug delivery
- 4.1.1 Nanoparticle distribution
- 4.1.2 Nanoparticle functionalization
- 4.1.3 Nanoparticle targeting
- 4.2 Nanomedicine and cancer
- 4.3 Nanomedicine and toxicity.
- 5. Nanoparticle technologies
- 5.1 Polymeric and polymer-drug conjugate nanoparticles
- 5.2 Micelle nanoparticles
- 5.3 Liposomes
- 5.4 Gold and silver nanoparticles
- 5.5 Metal oxide
- 5.6 Magnetic nanoparticles
- 5.7 Carbon nanotubes
- 5.8 Fullerenes
- 5.9 Peptides nanoparticles
- 5.10 Silica nanoparticles
- 5.11 Quantum dots
- 5.12 Dendrimers.
- 6. Nanomedicine applications in brain tumors
- 6.1 Brain tumor drug targeting
- 6.1.1 Systemic approaches
- 6.1.2 Physiological approaches
- 6.1.2.1 Receptor-mediated transcytosis
- 6.1.2.2 Adsorptive-mediated transcytosis
- 6.1.2.3 Efflux pump inhibition
- 6.1.2.4 Cell-mediated drug transport
- 6.1.3 Direct CNS approaches
- 6.1.3.1 Intracerebral routes
- 6.1.4 Drug modifications and prodrugs.
- 7. Experimental studies.
- 8. Conclusions
- References.